Amanote Research
Register
Sign In
Molecular Targeting and Treatment of EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibody L8A4
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-06-0141
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 15, 2006
Authors
W. Yang
Publisher
American Association for Cancer Research (AACR)
Related search
Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer
PLoS ONE
Multidisciplinary
Characterization of Monoclonal Antibody–Protein Antigen Complexes Using Small-Angle Scattering and Molecular Modeling
Antibodies
Drug Discovery
Allergy
Immunology
Conversion of a Murine Monoclonal Antibody A13 Targeting Epidermal Growth Factor Receptor to a Human Monoclonal Antibody by Guided Selection
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Polysialosyl Glycoconjugates Defined by Monoclonal Antibody M6704 Are Expressed in Human Gliomas and Embryonic Neurons.
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
Frontiers in Oncology
Cancer Research
Oncology
Monoclonal Antibody Targeting the Β-Barrel Assembly Machine ofEscherichia Coliis Bactericidal
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of Both Tick-Borne Encephalitis Virus and Louping Ill Virus
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Molecular Biological Analysis of Perfusion Culture of Hybridoma and Effective Production of Monoclonal Antibody Using Interleukin-6.
Kagaku Kogaku Ronbunshu
Chemistry
Chemical Engineering
Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma
Oncotarget
Oncology
